Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free UHT Stock Alerts

Universal Health Realty Income Trust (UHT) Financials

Universal Health Realty Income Trust logo
$43.14 +0.08 (+0.20%)
Closing price 03:59 PM Eastern
Extended Trading
$43.14 +0.00 (+0.00%)
As of 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Universal Health Realty Income Trust

Annual Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 24 -2.38 46 24 96 19 109 21 15 19 18
Consolidated Net Income / (Loss)		 24 17 46 24 19 19 109 21 15 19 18
Net Income / (Loss) Continuing Operations		 15 6.97 56 34 96 19 109 32 32 38 36
Total Pre-Tax Income 		21 2.52 26 32 26 26 29 31 31 37 35
Total Revenue		 64 51 72 82 154 78 84 91 95 99 99
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 64 51 72 82 154 78 84 91 95 99 99
Other Service Charges		 - - - 3.08 2.05 1.88 1.97 3.19 2.50 2.29 2.69
Net Realized & Unrealized Capital Gains on Investments		 - - - - - - - 0.00 -0.23 0.00 0.00
Other Non-Interest Income		 64 51 72 79 152 76 82 87 93 97 97
Total Non-Interest Expense		 43 48 48 50 51 52 55 60 64 62 64
Other Operating Expenses		 18 25 23 25 26 26 28 33 36 35 36
Depreciation Expense		 22 23 25 25 26 26 27 27 28 27 29
Other Gains / (Losses), net		 -5.69 4.46 30 1.77 -6.79 -6.56 80 1.19 1.21 1.28 1.70
Other Adjustments to Consolidated Net Income / (Loss)		 8.74 -9.36 -10 -9.98 - - - -11 -17 -19 -19
Basic Earnings per Share		 $1.78 $1.28 $3.35 $1.76 $1.38 $1.42 $7.94 $1.53 $1.12 $1.39 $1.27
Weighted Average Basic Shares Outstanding		 13.29M 13.46M 13.63M 13.72M 13.73M 13.74M 13.76M 13.77M 13.79M 13.80M 13.82M
Diluted Earnings per Share		 $1.78 $1.28 $3.35 $1.76 $1.38 $1.41 $7.92 $1.53 $1.11 $1.39 $1.27
Weighted Average Diluted Shares Outstanding		 13.30M 13.47M 13.63M 13.72M 13.75M 13.77M 13.78M 13.80M 13.81M 13.84M 13.86M
Weighted Average Basic & Diluted Shares Outstanding		 13.30M 13.40M 13.74M 13.70M 13.76M 13.77M 13.79M 13.80M 13.82M 13.85M 13.87M
Cash Dividends to Common per Share		 $2.56 $2.60 $2.64 $2.68 $2.72 $2.76 $2.80 $2.84 $2.88 $2.92 $2.96

Quarterly Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 3.87 3.59 5.30 5.28 4.00 4.66 4.78 4.49 4.02 4.32 5.02
Consolidated Net Income / (Loss)		 3.87 3.59 5.30 5.28 4.00 4.66 4.78 4.49 4.02 4.32 5.02
Net Income / (Loss) Continuing Operations		 8.34 8.18 9.85 9.86 8.79 9.58 9.45 9.21 8.83 8.97 9.47
Total Pre-Tax Income 		8.03 7.92 9.46 9.58 8.49 9.26 9.03 8.84 8.39 8.49 8.96
Total Revenue		 24 24 25 25 24 25 25 25 25 24 25
Net Interest Income / (Expense)		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 24 24 25 25 24 25 25 25 25 24 25
Other Service Charges		 0.66 0.59 0.63 0.56 0.55 0.55 0.54 0.56 0.81 0.77 0.60
Other Non-Interest Income		 24 24 25 24 24 24 24 24 24 24 24
Total Non-Interest Expense		 16 16 16 15 16 15 16 16 17 16 16
Other Operating Expenses		 9.19 8.91 8.87 8.34 9.00 8.59 8.67 9.03 9.01 8.86 8.62
Depreciation Expense		 7.01 7.25 6.81 6.81 7.01 6.80 6.85 6.99 7.90 7.12 6.95
Other Gains / (Losses), net		 0.31 0.25 0.38 0.27 0.30 0.32 0.41 0.37 0.44 0.48 0.51
Other Adjustments to Consolidated Net Income / (Loss)		 -4.47 -4.58 -4.55 -4.58 -4.79 -4.92 -4.67 -4.72 -4.82 -4.65 -4.45
Basic Earnings per Share		 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34 $0.35 $0.33 $0.29 $0.30 $0.36
Weighted Average Basic Shares Outstanding		 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M 13.81M 13.82M 13.83M 13.82M 13.83M
Diluted Earnings per Share		 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34 $0.34 $0.32 $0.29 $0.32 $0.36
Weighted Average Diluted Shares Outstanding		 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M 13.85M 13.86M 13.87M 13.86M 13.88M
Weighted Average Basic & Diluted Shares Outstanding		 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M 13.85M 13.87M 13.87M 13.87M 13.88M
Cash Dividends to Common per Share		 $0.72 - $0.73 - - - $0.74 $740.00 $740.00 - $0.75

Annual Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.03 0.04 -0.54 1.65 1.07 -0.37 17 -15 0.60 -1.12 -0.41
Net Cash From Operating Activities		 38 41 46 43 43 44 48 47 43 47 49
Net Cash From Continuing Operating Activities		 38 41 46 43 43 44 48 47 43 47 49
Net Income / (Loss) Continuing Operations		 24 17 46 24 19 19 109 21 15 19 18
Consolidated Net Income / (Loss)		 24 17 46 24 19 19 109 21 15 19 18
Depreciation Expense		 22 23 25 25 26 26 27 27 28 27 29
Amortization Expense		 -0.23 -0.23 -0.14 0.39 0.39 0.53 0.56 0.52 0.55 0.59 0.59
Non-Cash Adjustments to Reconcile Net Income		 -8.32 0.48 -29 -3.96 -1.25 0.91 -88 0.78 -0.76 -0.42 -0.95
Changes in Operating Assets and Liabilities, net		 0.83 0.25 4.13 -2.67 -1.32 -2.26 -1.73 -2.16 0.02 0.08 2.98
Net Cash From Investing Activities		 -44 -75 39 -7.96 -16 -27 -24 -37 -19 -14 -15
Net Cash From Continuing Investing Activities		 -44 -75 39 -7.96 -16 -27 -24 -37 -19 -14 -15
Purchase of Property, Leasehold Improvements and Equipment		 -17 -60 -9.04 -4.05 -5.11 -2.27 -13 -14 -7.62 0.00 0.00
Purchase of Investment Securities		 -26 -5.45 -8.42 -0.82 -2.13 -3.20 -20 -0.09 -4.06 -5.89 -6.80
Sale and/or Maturity of Investments		 1.35 0.85 70 0.00 2.77 0.00 25 0.00 7.39 0.00 0.00
Other Investing Activities, net		 -5.03 -9.84 -13 -3.09 -12 -22 -13 -22 -15 -7.98 -8.15
Net Cash From Financing Activities		 6.16 34 -86 -33 -25 -17 -6.54 -25 -23 -34 -35
Net Cash From Continuing Financing Activities		 6.16 34 -86 -33 -25 -17 -6.54 -25 -23 -34 -35
Issuance of Debt		 58 59 23 28 17 23 36 26 29 22 7.30
Issuance of Common Equity		 1.67 13 9.36 0.23 0.21 -0.03 0.22 0.18 0.15 -0.13 0.16
Repayment of Debt		 -18 -3.23 -81 -25 -4.20 -1.91 -2.08 -12 -12 -14 -0.94
Repurchase of Common Equity		 - - - 0.00 -0.22 -0.24 0.00 0.00 0.00 0.00 0.00
Payment of Dividends		 -34 -35 -36 -37 -37 -38 -39 -39 -40 -40 -41
Other Financing Activities, Net		 -1.11 -0.31 -0.45 - -0.04 -0.47 -1.84 -0.03 -0.22 -2.38 -0.04
Cash Interest Paid		 8.03 8.90 9.69 9.47 10 7.57 8.08 10 16 18 18

Quarterly Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1.10 -0.15 -0.52 -2.12 0.80 0.73 -0.12 -0.42 0.36 -0.23 0.38
Net Cash From Operating Activities		 10 10 12 12 9.89 13 12 14 10 14 12
Net Cash From Continuing Operating Activities		 10 10 12 12 9.89 13 12 14 10 14 12
Net Income / (Loss) Continuing Operations		 3.87 3.59 5.30 5.28 4.00 4.66 4.78 4.49 4.02 4.32 5.02
Consolidated Net Income / (Loss)		 3.87 3.59 5.30 5.28 4.00 4.66 4.78 4.49 4.02 4.32 5.02
Depreciation Expense		 7.01 7.25 6.81 6.81 7.01 6.80 6.85 6.99 7.90 7.12 6.95
Amortization Expense		 0.14 0.16 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15
Non-Cash Adjustments to Reconcile Net Income		 0.81 -1.33 -0.18 0.59 -0.88 1.32 -0.34 0.21 -1.14 -0.23 -0.18
Changes in Operating Assets and Liabilities, net		 -1.67 0.79 -0.34 -0.69 -0.38 0.23 0.18 1.84 -0.72 2.24 0.01
Net Cash From Investing Activities		 -11 0.74 -8.95 -0.72 -1.50 -2.71 -1.90 -8.79 -1.75 -2.52 -4.46
Net Cash From Continuing Investing Activities		 -11 0.74 -8.95 -0.72 -1.50 -2.71 -1.90 -8.79 -1.75 -2.52 -4.46
Purchase of Property, Leasehold Improvements and Equipment		 -7.60 -0.02 0.00 - - - 0.00 - - - 0.00
Purchase of Investment Securities		 -0.19 - -5.89 - - - -0.33 -6.47 - - -0.19
Sale and/or Maturity of Investments		 - 3.89 0.00 - - - 0.00 - - - 0.00
Other Investing Activities, net		 -3.17 -3.14 -3.05 -0.72 -1.50 -2.71 -1.57 -2.31 -1.75 -2.52 -4.27
Net Cash From Financing Activities		 -0.31 -11 -3.31 -14 -7.60 -9.72 -9.84 -5.32 -8.09 -11 -7.12
Net Cash From Continuing Financing Activities		 -0.31 -11 -3.31 -14 -7.60 -9.72 -9.84 -5.32 -8.09 -11 -7.12
Issuance of Debt		 10 5.10 7.05 9.25 4.85 1.15 0.60 5.30 2.25 -0.85 3.30
Issuance of Common Equity		 0.04 0.03 0.04 -0.05 0.03 -0.15 0.00 -0.04 - 0.16 0.00
Repayment of Debt		 -0.43 -6.47 -0.37 -13 -0.31 -0.32 -0.32 -0.33 -0.15 -0.15 -0.15
Repurchase of Common Equity		 - - - - - - 0.04 - 0.04 -0.12 0.04
Payment of Dividends		 -9.93 -10.00 -10 -10 -10 -10 -10 -10 -10 -10 -10
Other Financing Activities, Net		 -0.09 - -0.03 -0.02 -2.08 -0.25 0.00 - - -0.04 0.00
Cash Interest Paid		 4.30 4.23 3.76 4.46 4.92 4.77 4.52 4.30 4.63 4.43 4.51

Annual Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 459 525 490 484 489 494 598 608 596 581 565
Cash and Due from Banks		 3.89 3.93 3.39 5.04 6.11 5.74 23 7.61 8.21 7.10 6.69
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 390 447 446 438 441 453 450 461 455 437 421
Intangible Assets		 20 24 21 17 15 12 9.97 9.45 9.11 7.33 5.64
Other Assets		 38 43 14 15 18 15 104 107 124 130 131
Total Liabilities & Shareholders' Equity		 459 525 490 484 489 494 598 608 596 581 565
Total Liabilities		 263 333 279 285 307 335 363 378 395 401 413
Non-Interest Bearing Deposits		 3.84 5.32 10 12 11 11 10 11 11 11 12
Short-Term Debt		 142 202 181 196 213 236 272 298 327 349 356
Accrued Interest Payable		 0.50 0.63 0.54 0.45 0.37 0.35 0.35 0.37 0.49 0.69 0.91
Long-Term Debt		 110 114 75 65 61 59 57 45 33 19 18
Other Long-Term Liabilities		 6.81 12 12 12 22 29 24 24 24 21 25
Total Equity & Noncontrolling Interests		 195 191 211 199 182 159 235 229 201 180 152
Total Preferred & Common Equity		 195 191 211 199 182 159 235 229 201 180 152
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 195 191 211 199 182 159 235 229 201 180 152
Common Stock		 242 256 265 266 267 268 269 270 271 271 272
Retained Earnings		 -47 -65 -55 -68 -86 -105 -34 -53 -77 -98 -122
Accumulated Other Comprehensive Income / (Loss)		 -0.09 0.11 0.14 0.13 1.01 -3.82 1.11 12 7.31 6.41 1.64

Quarterly Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 609 604 603 608 596 587 584 573 573 568 564
Cash and Due from Banks		 8.10 8.12 9.46 8.36 7.70 5.58 6.37 6.97 6.55 6.92 7.06
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 461 459 458 461 450 445 441 432 428 422 421
Intangible Assets		 9.94 8.88 8.34 9.65 8.65 8.19 7.76 6.89 6.46 6.05 5.26
Other Assets		 107 107 107 107 130 128 129 128 132 133 131
Total Liabilities & Shareholders' Equity		 609 604 603 608 596 587 584 573 573 568 564
Total Liabilities		 376 382 386 398 400 396 403 401 408 409 416
Non-Interest Bearing Deposits		 9.91 11 11 12 11 11 11 11 11 11 12
Short-Term Debt		 290 308 311 322 334 343 348 350 355 357 360
Accrued Interest Payable		 0.35 0.34 0.34 0.33 1.09 1.02 0.74 0.66 0.89 0.89 0.66
Long-Term Debt		 50 40 40 39 33 20 20 19 19 19 18
Other Long-Term Liabilities		 25 22 24 25 21 21 24 21 22 22 25
Total Equity & Noncontrolling Interests		 234 222 217 210 196 191 182 172 165 159 148
Total Preferred & Common Equity		 234 222 217 210 196 191 182 172 165 159 148
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 234 222 217 210 196 191 182 172 165 159 148
Common Stock		 269 270 270 270 271 271 271 271 272 272 273
Retained Earnings		 -48 -58 -64 -70 -82 -86 -93 -104 -109 -116 -127
Accumulated Other Comprehensive Income / (Loss)		 13 10 11 10 7.50 6.44 3.26 4.19 2.73 2.13 2.15

Annual Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 13,325,893.00 13,598,144.00 13,734,618.00 13,745,924.00 13,757,061.00 13,770,519.00 13,784,412.00 - - - 13,873,618.00
DEI Adjusted Shares Outstanding		 13,325,893.00 13,598,144.00 13,734,618.00 13,745,924.00 13,757,061.00 13,770,519.00 13,784,412.00 - - - 13,873,618.00
DEI Earnings Per Adjusted Shares Outstanding		 1.78 1.27 3.32 1.76 1.38 1.41 7.92 - - - 1.27
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.96% -20.59% 42.47% 13.21% 88.42% -49.45% 7.92% 7.64% 5.21% 3.85% 0.18%
EBITDA Growth		 7.30% -40.63% 93.65% 17.91% 123.62% -59.66% 9.19% 1.48% 2.86% 9.11% -0.91%
EBIT Growth		 8.35% -87.81% 855.75% 34.80% 217.61% -74.73% 11.00% 6.24% 1.47% 18.25% -5.53%
NOPAT Growth		 8.35% -87.81% 855.75% 34.80% -20.53% 0.99% 11.00% 6.24% 1.47% 18.25% -5.53%
Net Income Growth		 -54.04% -27.34% 165.00% -46.96% -21.62% 2.55% 461.35% -80.67% -27.02% 24.90% -8.45%
EPS Growth		 -55.39% -28.09% 161.72% -47.46% -21.59% 2.17% 461.70% -80.68% -27.45% 25.23% -8.63%
Operating Cash Flow Growth		 16.41% 6.69% 12.94% -6.69% -0.64% 3.65% 7.95% -1.93% -8.26% 9.25% 4.65%
Free Cash Flow Firm Growth		 72.86% -536.56% 212.13% -38.37% -23.47% -9.54% -396.82% 128.14% 86.77% 15.84% 12.41%
Invested Capital Growth		 7.09% 13.33% -7.89% -1.52% -0.97% -0.29% 24.22% 1.39% -2.02% -2.25% -3.79%
Revenue Q/Q Growth		 -5.77% -22.47% 30.63% -18.13% 166.07% 0.00% 0.00% 3.09% -0.04% 0.56% -0.17%
EBITDA Q/Q Growth		 -8.15% -42.34% 68.15% -23.22% 292.92% 100.95% 106.47% 10.56% -7.23% 1.37% -0.69%
EBIT Q/Q Growth		 -12.86% -88.50% 442.96% -35.87% 1,589.59% 0.00% 0.00% 23.95% -14.78% 3.77% -2.16%
NOPAT Q/Q Growth		 -12.86% -88.50% 442.96% -38.35% 322.75% 0.00% 0.00% 4.56% -2.53% 3.77% -2.16%
Net Income Q/Q Growth		 -33.39% 0.55% 3.68% -6.39% 8.12% -4.13% 384.09% -80.29% -11.69% 5.88% -1.88%
EPS Q/Q Growth		 -34.32% 0.00% 3.40% -6.38% 7.81% -4.08% 382.93% -80.28% -11.90% 6.11% -1.55%
Operating Cash Flow Q/Q Growth		 5.44% 0.25% 3.13% -5.90% 2.98% 1.18% 0.20% 1.65% -4.10% 6.10% 0.91%
Free Cash Flow Firm Q/Q Growth		 -148.67% -30.01% 144.42% -36.70% 64.84% 973.11% -118.51% 138.94% 22.63% -14.14% 10.22%
Invested Capital Q/Q Growth		 4.17% 2.37% -1.37% -0.81% 0.89% 1.16% 16.07% -0.36% -1.88% -0.23% -1.34%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 66.63% 49.82% 67.71% 70.52% 83.70% 66.80% 67.59% 63.72% 62.30% 65.45% 64.74%
EBIT Margin		 32.27% 4.95% 33.22% 39.56% 66.69% 33.33% 34.29% 33.84% 32.64% 37.16% 35.05%
Profit (Net Income) Margin		 37.05% 33.90% 63.06% 29.54% 12.29% 24.93% 129.67% 23.29% 16.15% 19.43% 17.75%
Tax Burden Percent		 114.80% 684.49% 174.99% 74.67% 73.65% 74.78% 378.20% 68.81% 49.49% 52.27% 50.65%
Interest Burden Percent		 100.00% 100.00% 108.46% 100.00% 25.02% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 4.77% 0.53% 4.94% 6.99% 5.63% 5.72% 5.67% 5.40% 5.50% 6.64% 6.47%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.08% 5.70% 12.48% 3.82% 3.09% 3.41% 31.41% 2.55% 1.02% 1.81% 1.85%
Return on Net Nonoperating Assets (RNNOA)		 7.09% 8.39% 17.77% 4.84% 4.35% 5.70% 49.70% 3.69% 1.67% 3.47% 4.14%
Return on Equity (ROE)		 11.86% 8.91% 22.71% 11.83% 9.97% 11.41% 55.37% 9.09% 7.16% 10.11% 10.61%
Cash Return on Invested Capital (CROIC)		 -2.07% -11.97% 13.15% 8.52% 6.60% 6.01% -15.94% 4.02% 7.53% 8.92% 10.33%
Operating Return on Assets (OROA)		 4.65% 0.51% 4.74% 6.66% 21.16% 5.29% 5.28% 5.09% 5.17% 6.25% 6.07%
Return on Assets (ROA)		 5.34% 3.50% 8.99% 4.97% 3.90% 3.96% 19.99% 3.50% 2.56% 3.27% 3.07%
Return on Common Equity (ROCE)		 11.86% 8.91% 22.71% 11.83% 9.97% 11.41% 55.37% 9.09% 7.16% 10.11% 10.61%
Return on Equity Simple (ROE_SIMPLE)		 12.15% 9.00% 21.67% 12.18% 10.44% 12.23% 46.39% 9.21% 7.66% 10.71% 11.56%
Net Operating Profit after Tax (NOPAT)		 21 2.52 24 32 26 26 29 31 31 37 35
NOPAT Margin		 32.27% 4.95% 33.22% 39.56% 16.69% 33.33% 34.29% 33.84% 32.64% 37.16% 35.05%
Net Nonoperating Expense Percent (NNEP)		 -1.31% -5.18% -7.54% 3.17% 2.54% 2.31% -25.74% 2.85% 4.48% 4.83% 4.62%
SG&A Expenses to Revenue		 4.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 67.73% 95.05% 66.78% 60.44% 33.31% 66.67% 65.71% 66.16% 67.36% 62.84% 64.95%
Earnings before Interest and Taxes (EBIT)		 21 2.52 24 32 103 26 29 31 31 37 35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 43 25 49 58 129 52 57 58 59 65 64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.32 3.31 3.61 3.26 7.03 4.57 2.98 2.51 2.77 2.87 3.50
Price to Tangible Book Value (P/TBV)		 2.58 3.79 4.01 3.58 7.64 4.93 3.12 2.62 2.90 2.99 3.64
Price to Revenue (P/Rev)		 7.08 12.49 10.52 7.91 8.28 9.30 8.34 6.35 5.83 5.20 5.38
Price to Earnings (P/E)		 19.12 0.00 16.68 26.79 13.29 37.33 6.43 27.29 36.09 26.79 30.32
Dividend Yield		 7.53% 5.58% 4.76% 5.68% 2.93% 5.24% 5.50% 6.81% 7.16% 7.85% 7.69%
Earnings Yield		 5.23% 0.00% 5.99% 3.73% 7.52% 2.68% 15.55% 3.66% 2.77% 3.73% 3.30%
Enterprise Value to Invested Capital (EV/IC)		 1.57 1.87 2.17 1.97 3.39 2.24 1.79 1.59 1.62 1.60 1.71
Enterprise Value to Revenue (EV/Rev)		 10.97 18.62 14.02 11.04 10.01 13.01 11.98 10.05 9.51 8.85 9.09
Enterprise Value to EBITDA (EV/EBITDA)		 16.46 37.39 20.70 15.66 11.96 19.48 17.72 15.78 15.27 13.52 14.05
Enterprise Value to EBIT (EV/EBIT)		 33.99 376.07 42.18 27.91 15.01 39.04 34.94 29.71 29.15 23.82 25.94
Enterprise Value to NOPAT (EV/NOPAT)		 33.99 376.07 42.18 27.91 60.01 39.04 34.94 29.71 29.15 23.82 25.94
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.37 23.22 22.04 21.07 36.23 22.96 21.13 19.46 21.12 18.68 18.37
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 15.83 22.91 51.14 37.14 0.00 39.90 21.27 17.74 16.24
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.29 1.65 1.22 1.32 1.51 1.86 1.40 1.50 1.79 2.05 2.46
Long-Term Debt to Equity		 0.56 0.60 0.36 0.33 0.33 0.37 0.24 0.20 0.16 0.11 0.12
Financial Leverage		 1.16 1.47 1.42 1.27 1.41 1.67 1.58 1.45 1.63 1.91 2.24
Leverage Ratio		 2.22 2.55 2.53 2.38 2.56 2.88 2.77 2.60 2.80 3.09 3.45
Compound Leverage Factor		 2.22 2.55 2.74 2.38 0.64 2.88 2.77 2.60 2.80 3.09 3.45
Debt to Total Capital		 56.40% 62.27% 54.91% 56.81% 60.10% 64.98% 58.28% 59.94% 64.14% 67.22% 71.09%
Short-Term Debt to Total Capital		 31.78% 39.74% 38.77% 42.71% 46.76% 52.02% 48.20% 52.12% 58.28% 63.69% 67.59%
Long-Term Debt to Total Capital		 24.62% 22.53% 16.14% 14.11% 13.34% 12.97% 10.08% 7.82% 5.86% 3.53% 3.50%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 43.60% 37.73% 45.09% 43.19% 39.90% 35.02% 41.72% 40.06% 35.86% 32.78% 28.91%
Debt to EBITDA		 5.92 12.48 5.23 4.52 2.12 5.66 5.78 5.94 6.05 5.68 5.83
Net Debt to EBITDA		 5.83 12.32 5.16 4.44 2.07 5.55 5.38 5.81 5.91 5.57 5.73
Long-Term Debt to EBITDA		 2.59 4.51 1.54 1.12 0.47 1.13 1.00 0.77 0.55 0.30 0.29
Debt to NOPAT		 12.23 125.53 10.67 8.06 10.63 11.35 11.39 11.18 11.55 10.01 10.78
Net Debt to NOPAT		 12.04 123.97 10.53 7.91 10.39 11.13 10.61 10.93 11.29 9.82 10.58
Long-Term Debt to NOPAT		 5.34 45.41 3.14 2.00 2.36 2.26 1.97 1.46 1.06 0.53 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -8.98 -57 64 39 30 27 -81 23 43 49 56
Operating Cash Flow to CapEx		 258.57% 67.45% 508.90% 1,059.17% 835.49% 1,951.02% 367.43% 343.65% 563.50% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.14 0.10 0.14 0.17 0.32 0.16 0.15 0.15 0.16 0.17 0.17
Fixed Asset Turnover		 0.17 0.12 0.16 0.19 0.35 0.17 0.19 0.20 0.21 0.22 0.23
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 447 507 467 460 455 454 564 572 560 548 527
Invested Capital Turnover		 0.15 0.11 0.15 0.18 0.34 0.17 0.17 0.16 0.17 0.18 0.18
Increase / (Decrease) in Invested Capital		 30 60 -40 -7.08 -4.46 -1.33 110 7.83 -12 -13 -21
Enterprise Value (EV)		 701 946 1,014 904 1,545 1,015 1,008 911 907 876 902
Market Capitalization		 453 634 761 648 1,278 726 702 576 556 515 534
Book Value per Share		 $14.64 $14.07 $15.33 $14.45 $13.21 $11.55 $17.07 $16.60 $14.54 $12.96 $10.98
Tangible Book Value per Share		 $13.15 $12.32 $13.83 $13.18 $12.15 $10.69 $16.35 $15.91 $13.88 $12.43 $10.58
Total Capital		 447 507 467 460 455 454 564 572 560 548 527
Total Debt		 252 316 256 261 274 295 329 343 359 368 375
Total Long-Term Debt		 110 114 75 65 61 59 57 45 33 19 18
Net Debt		 248 312 253 256 268 289 306 335 351 361 368
Capital Expenditures (CapEx)		 15 60 9.04 4.05 5.11 2.27 13 14 7.62 0.00 0.00
Net Nonoperating Expense (NNE)		 -3.05 -15 -22 8.21 6.79 6.56 -80 9.56 16 18 17
Net Nonoperating Obligations (NNO)		 252 316 256 261 274 295 329 343 359 368 375
Total Depreciation and Amortization (D&A)		 22 23 25 25 26 26 28 27 28 28 29
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.78 $1.28 $3.35 $1.76 $1.38 $1.42 $7.94 $1.53 $1.12 $1.39 $1.27
Adjusted Weighted Average Basic Shares Outstanding		 13.29M 13.46M 13.63M 13.72M 13.73M 13.74M 13.76M 13.77M 13.79M 13.80M 13.82M
Adjusted Diluted Earnings per Share		 $1.78 $1.28 $3.35 $1.76 $1.38 $1.41 $7.92 $1.53 $1.11 $1.39 $1.27
Adjusted Weighted Average Diluted Shares Outstanding		 13.30M 13.47M 13.63M 13.72M 13.75M 13.77M 13.78M 13.80M 13.81M 13.84M 13.86M
Adjusted Basic & Diluted Earnings per Share		 $1.78 $0.00 $0.00 $0.00 $1.38 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.33M 13.60M 13.74M 13.75M 13.76M 13.77M 13.79M 13.80M 13.82M 13.85M 13.87M
Normalized Net Operating Profit after Tax (NOPAT)		 14 1.76 17 23 18 18 20 21 22 26 24
Normalized NOPAT Margin		 22.59% 3.47% 23.26% 27.69% 11.68% 23.33% 24.00% 23.69% 22.85% 26.01% 24.53%
Pre Tax Income Margin		 32.27% 4.95% 36.03% 39.56% 16.69% 33.33% 34.29% 33.84% 32.64% 37.16% 35.05%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 144.21% 204.29% 79.03% 152.22% 197.27% 195.26% 35.30% 185.66% 258.21% 210.01% 232.99%
Augmented Payout Ratio		 144.21% 204.29% 79.03% 152.22% 198.44% 196.47% 35.30% 185.66% 258.21% 210.01% 232.99%

Quarterly Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 13,850,613.00 13,851,507.00 13,874,130.00 13,873,618.00 13,874,643.00
DEI Adjusted Shares Outstanding		 - - - - - - 13,850,613.00 13,851,507.00 13,874,130.00 13,873,618.00 13,874,643.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - 0.34 0.32 0.29 0.31 0.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 9.35% -0.17% 8.25% 3.90% 1.12% 2.30% -2.36% 0.54% 3.30% -0.69% -0.08%
EBITDA Growth		 7.59% -23.19% 13.06% 15.14% 3.08% 5.69% -2.38% -3.34% 5.11% -2.76% 0.19%
EBIT Growth		 9.62% -40.51% 21.55% 29.79% 5.79% 16.86% -4.53% -7.72% -1.13% -8.29% -0.85%
NOPAT Growth		 9.62% -9.24% 21.55% 29.79% 5.79% 16.86% -4.53% -7.72% -1.13% -8.29% -0.85%
Net Income Growth		 -20.13% -36.19% 18.86% 51.78% 3.23% 29.72% -9.87% -14.86% 0.48% -7.23% 5.07%
EPS Growth		 -20.00% -36.59% 18.75% 52.00% 3.57% 30.77% -10.53% -15.79% 0.00% -5.88% 5.88%
Operating Cash Flow Growth		 6.12% -14.92% 16.59% -1.04% -2.65% 25.81% -1.08% 12.85% 3.09% 3.38% 2.92%
Free Cash Flow Firm Growth		 113.49% 2,068.56% 217.95% 156.26% 181.04% 12.41% 76.46% -0.17% -23.95% 33.82% -22.25%
Invested Capital Growth		 -0.50% -2.02% -1.42% -2.50% -3.87% -2.25% -3.90% -2.69% -2.71% -3.79% -2.79%
Revenue Q/Q Growth		 1.75% -0.56% 4.37% -1.62% -0.97% 0.60% -0.38% 1.30% 1.75% -3.28% 0.23%
EBITDA Q/Q Growth		 5.67% 1.01% 7.09% 0.72% -5.39% 3.58% -1.09% -0.28% 2.88% -4.17% 1.92%
EBIT Q/Q Growth		 8.68% -1.27% 19.44% 1.28% -11.41% 9.06% -2.43% -2.10% -5.09% 1.16% 5.49%
NOPAT Q/Q Growth		 8.68% -1.27% 19.44% 1.28% -11.41% 9.06% -2.43% -2.10% -5.09% 1.16% 5.49%
Net Income Q/Q Growth		 11.39% -7.21% 47.51% -0.45% -24.24% 16.61% 2.49% -5.97% -10.60% 7.67% 16.07%
EPS Q/Q Growth		 12.00% -7.14% 46.15% 0.00% -23.68% 17.24% 0.00% -5.88% -9.38% 10.34% 12.50%
Operating Cash Flow Q/Q Growth		 -17.07% 2.88% 12.27% 3.31% -18.42% 32.95% -11.72% 17.86% -25.47% 33.32% -12.11%
Free Cash Flow Firm Q/Q Growth		 17.16% 78.85% -9.84% 35.64% 28.49% -28.46% 41.53% -23.26% -2.12% 25.88% -17.77%
Invested Capital Q/Q Growth		 0.59% -1.88% 0.40% -1.61% -0.82% -0.23% -1.29% -0.38% -0.83% -1.34% -0.27%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 62.66% 63.65% 65.31% 66.86% 63.87% 65.76% 65.30% 64.28% 64.99% 64.39% 65.47%
EBIT Margin		 33.13% 32.89% 37.64% 38.75% 34.66% 37.57% 36.80% 35.56% 33.18% 34.70% 36.52%
Profit (Net Income) Margin		 15.98% 14.92% 21.08% 21.33% 16.32% 18.91% 19.46% 18.06% 15.87% 17.67% 20.46%
Tax Burden Percent		 48.25% 45.35% 56.01% 55.05% 47.08% 50.34% 52.88% 50.79% 47.84% 50.92% 56.03%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 5.52% 5.54% 6.46% 6.79% 6.09% 6.71% 6.57% 6.42% 6.09% 6.40% 6.79%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.33% 4.31% 5.30% 5.58% 4.86% 5.45% 5.41% 5.24% 4.91% 5.28% 5.74%
Return on Net Nonoperating Assets (RNNOA)		 6.85% 7.03% 9.04% 9.78% 9.03% 10.42% 10.78% 10.83% 10.72% 11.82% 13.38%
Return on Equity (ROE)		 12.37% 12.57% 15.50% 16.56% 15.12% 17.14% 17.34% 17.25% 16.80% 18.23% 20.17%
Cash Return on Invested Capital (CROIC)		 6.07% 7.53% 7.21% 8.78% 10.27% 8.92% 10.56% 9.25% 9.30% 10.33% 9.34%
Operating Return on Assets (OROA)		 5.19% 5.21% 6.10% 6.40% 5.72% 6.32% 6.19% 6.05% 5.72% 6.01% 6.37%
Return on Assets (ROA)		 2.51% 2.36% 3.42% 3.52% 2.70% 3.18% 3.27% 3.07% 2.74% 3.06% 3.57%
Return on Common Equity (ROCE)		 12.37% 12.57% 15.50% 16.56% 15.12% 17.14% 17.34% 17.25% 16.80% 18.23% 20.17%
Return on Equity Simple (ROE_SIMPLE)		 8.29% 0.00% 8.27% 9.46% 10.00% 0.00% 10.87% 10.85% 11.32% 0.00% 12.08%
Net Operating Profit after Tax (NOPAT)		 8.03 7.92 9.46 9.58 8.49 9.26 9.03 8.84 8.39 8.49 8.96
NOPAT Margin		 33.13% 32.89% 37.64% 38.75% 34.66% 37.57% 36.80% 35.56% 33.18% 34.70% 36.52%
Net Nonoperating Expense Percent (NNEP)		 1.18% 1.23% 1.17% 1.21% 1.23% 1.26% 1.16% 1.18% 1.18% 1.12% 1.06%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.87% 67.11% 62.36% 61.25% 65.34% 62.43% 63.20% 64.44% 66.82% 65.30% 63.48%
Earnings before Interest and Taxes (EBIT)		 8.03 7.92 9.46 9.58 8.49 9.26 9.03 8.84 8.39 8.49 8.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 15 16 17 16 16 16 16 16 16 16
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.48 2.77 2.53 2.84 3.49 2.87 3.06 3.35 3.43 3.50 3.80
Price to Tangible Book Value (P/TBV)		 2.59 2.90 2.65 2.96 3.64 2.99 3.19 3.49 3.56 3.64 3.94
Price to Revenue (P/Rev)		 5.46 5.83 5.12 5.51 6.44 5.20 5.36 5.62 5.47 5.38 5.66
Price to Earnings (P/E)		 29.86 36.09 30.66 29.99 34.88 26.79 28.19 30.88 30.28 30.32 31.46
Dividend Yield		 7.62% 7.16% 8.02% 7.41% 6.36% 7.85% 7.69% 7.36% 7.53% 7.69% 7.34%
Earnings Yield		 3.35% 2.77% 3.26% 3.33% 2.87% 3.73% 3.55% 3.24% 3.30% 3.30% 3.18%
Enterprise Value to Invested Capital (EV/IC)		 1.53 1.62 1.52 1.62 1.81 1.60 1.64 1.71 1.71 1.71 1.77
Enterprise Value to Revenue (EV/Rev)		 9.15 9.51 8.80 9.15 10.10 8.85 9.03 9.34 9.18 9.09 9.40
Enterprise Value to EBITDA (EV/EBITDA)		 13.64 15.27 13.97 14.16 15.56 13.52 13.80 14.42 14.11 14.05 14.51
Enterprise Value to EBIT (EV/EBIT)		 23.91 29.15 26.11 25.67 28.05 23.82 24.45 25.84 25.67 25.94 26.88
Enterprise Value to NOPAT (EV/NOPAT)		 27.35 29.15 26.11 25.67 28.05 23.82 24.45 25.84 25.67 25.94 26.88
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.50 21.12 19.20 20.20 22.50 18.68 19.00 19.04 18.75 18.37 18.86
Enterprise Value to Free Cash Flow (EV/FCFF)		 25.11 21.27 20.95 18.26 17.29 17.74 15.25 18.22 18.10 16.24 18.72
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.72 1.79 1.86 1.90 2.02 2.05 2.14 2.26 2.37 2.46 2.56
Long-Term Debt to Equity		 0.19 0.16 0.17 0.10 0.11 0.11 0.11 0.11 0.12 0.12 0.12
Financial Leverage		 1.58 1.63 1.71 1.75 1.86 1.91 1.99 2.07 2.18 2.24 2.33
Leverage Ratio		 2.74 2.80 2.87 2.92 3.04 3.09 3.17 3.26 3.39 3.45 3.55
Compound Leverage Factor		 2.74 2.80 2.87 2.92 3.04 3.09 3.17 3.26 3.39 3.45 3.55
Debt to Total Capital		 63.18% 64.14% 65.08% 65.55% 66.92% 67.22% 68.16% 69.34% 70.32% 71.09% 71.88%
Short-Term Debt to Total Capital		 56.29% 58.28% 59.30% 61.94% 63.34% 63.69% 64.64% 65.87% 66.84% 67.59% 68.40%
Long-Term Debt to Total Capital		 6.88% 5.86% 5.78% 3.61% 3.58% 3.53% 3.52% 3.47% 3.48% 3.50% 3.48%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 36.82% 35.86% 34.92% 34.45% 33.08% 32.78% 31.84% 30.66% 29.68% 28.91% 28.12%
Debt to EBITDA		 5.64 6.05 5.97 5.72 5.75 5.68 5.72 5.85 5.81 5.83 5.88
Net Debt to EBITDA		 5.51 5.91 5.85 5.63 5.65 5.57 5.61 5.75 5.70 5.73 5.77
Long-Term Debt to EBITDA		 0.61 0.55 0.53 0.31 0.31 0.30 0.30 0.29 0.29 0.29 0.28
Debt to NOPAT		 11.30 11.55 11.17 10.37 10.36 10.01 10.13 10.48 10.57 10.78 10.89
Net Debt to NOPAT		 11.04 11.29 10.93 10.21 10.18 9.82 9.94 10.30 10.38 10.58 10.69
Long-Term Debt to NOPAT		 1.23 1.06 0.99 0.57 0.55 0.53 0.52 0.53 0.52 0.53 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 11 19 18 24 31 22 31 24 23 29 24
Operating Cash Flow to CapEx		 133.75% 47,522.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.16 0.16 0.16 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17
Fixed Asset Turnover		 0.21 0.21 0.21 0.22 0.22 0.22 0.22 0.23 0.23 0.23 0.23
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 571 560 563 554 549 548 541 539 534 527 526
Invested Capital Turnover		 0.17 0.17 0.17 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.19
Increase / (Decrease) in Invested Capital		 -2.85 -12 -8.08 -14 -22 -13 -22 -15 -15 -21 -15
Enterprise Value (EV)		 873 907 856 898 995 876 889 921 912 902 932
Market Capitalization		 521 556 498 541 634 515 527 554 543 534 562
Book Value per Share		 $15.22 $14.54 $14.24 $13.79 $13.12 $12.96 $12.43 $11.92 $11.43 $10.98 $10.65
Tangible Book Value per Share		 $14.52 $13.88 $13.62 $13.20 $12.56 $12.43 $11.93 $11.46 $10.99 $10.58 $10.27
Total Capital		 571 560 563 554 549 548 541 539 534 527 526
Total Debt		 361 359 366 363 367 368 369 374 376 375 378
Total Long-Term Debt		 39 33 33 20 20 19 19 19 19 18 18
Net Debt		 352 351 358 357 361 361 362 367 369 368 371
Capital Expenditures (CapEx)		 7.60 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 4.15 4.33 4.16 4.31 4.49 4.60 4.26 4.35 4.38 4.17 3.94
Net Nonoperating Obligations (NNO)		 361 359 366 363 367 368 369 374 376 375 378
Total Depreciation and Amortization (D&A)		 7.15 7.41 6.96 6.95 7.16 6.95 7.00 7.14 8.05 7.27 7.10
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34 $0.35 $0.33 $0.29 $0.30 $0.36
Adjusted Weighted Average Basic Shares Outstanding		 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M 13.81M 13.82M 13.83M 13.82M 13.83M
Adjusted Diluted Earnings per Share		 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34 $0.34 $0.32 $0.29 $0.32 $0.36
Adjusted Weighted Average Diluted Shares Outstanding		 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M 13.85M 13.86M 13.87M 13.86M 13.88M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M 13.85M 13.87M 13.87M 13.87M 13.88M
Normalized Net Operating Profit after Tax (NOPAT)		 5.62 5.55 6.62 6.71 5.94 6.48 6.32 6.19 5.88 5.94 6.27
Normalized NOPAT Margin		 23.19% 23.02% 26.35% 27.12% 24.26% 26.30% 25.76% 24.89% 23.22% 24.29% 25.56%
Pre Tax Income Margin		 33.13% 32.89% 37.64% 38.75% 34.66% 37.57% 36.80% 35.56% 33.18% 34.70% 36.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 227.19% 258.21% 245.76% 222.18% 221.51% 210.01% 216.69% 227.14% 227.72% 232.99% 230.70%
Augmented Payout Ratio		 227.19% 258.21% 245.76% 222.18% 221.51% 210.01% 216.69% 226.67% 227.17% 232.99% 230.69%

Financials Breakdown Chart

Key Financial Trends

Universal Health Realty Income Trust (NYSE: UHT) continued to post steady quarterly profitability in Q1 2026, but the bigger picture shows a business that is highly leveraged, pays out most of its earnings as dividends, and has seen only modest top-line growth over the last several years.

For retail investors, UHT still looks like a classic income-oriented REIT: earnings and operating cash flow are positive, but debt and dividend coverage deserve close attention.

  • Q1 2026 net income increased year over year to $5.0 million from $4.0 million in Q1 2025, showing improved bottom-line performance.
  • Operating cash flow remains solid, with Q1 2026 cash from operations at $11.95 million, up from $11.61 million in Q1 2025.
  • Revenue edged higher to $24.5 million in Q1 2026, compared with $24.5 million in Q1 2025 and $24.4 million in Q4 2025, indicating stable demand.
  • Equity increased quarter over quarter to $147.8 million from $158.6 million? Actually Q1 2026 common equity was $147.8 million versus $158.6 million in Q3 2025, reflecting some erosion in book equity but still a meaningful capital base.
  • Depreciation remains a major non-cash add-back, which helps cash flow but also reflects the capital-intensive nature of the portfolio.
  • Cash balances are relatively modest at $7.1 million in Q1 2026, so liquidity depends heavily on ongoing operating cash generation.
  • Dividend payout remains high, with Q1 2026 cash dividends of $0.745 per share versus basic EPS of $0.36, suggesting the trust is distributing more than current earnings.
  • Debt levels remain elevated, with total debt of roughly $377.8 million at Q1 2026 compared with total equity of $147.8 million.
  • Interest burden is significant, as Q1 2026 cash interest paid was $4.5 million, a sizable drag on cash available for reinvestment or dividend growth.
  • Balance-sheet leverage is high relative to assets, with liabilities of $416.0 million against total assets of $563.8 million, leaving limited margin for error if property values weaken or borrowing costs rise.

Looking at the longer trend, UHT’s revenue has been fairly flat over the past four years, generally hovering around the mid-$20 million range per quarter. Net income has also stayed positive, but it has not shown strong growth. That pattern suggests a stable but low-growth REIT rather than a fast-expanding one.

On the balance sheet, total assets have declined from about $596.2 million in Q1 2024 to $563.8 million in Q1 2026, while liabilities have stayed high. Retained earnings remain deeply negative, which is common for REITs over long periods of dividend distributions, but it also highlights how much value has been returned to shareholders rather than reinvested.

Bottom line: UHT appears financially stable enough to keep generating income and paying dividends, but investors should watch leverage, interest costs, and dividend coverage closely. The stock may appeal to income-focused investors, but it does not look like a low-risk balance sheet story.

07/13/26 08:25 PM ETAI Generated. May Contain Errors.

Universal Health Realty Income Trust Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Universal Health Realty Income Trust's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

The last 5 years of Universal Health Realty Income Trust's net income performance:
  • 2021: $109.17 million
  • 2022: $21.10 million
  • 2023: $15.40 million
  • 2024: $19.23 million
  • 2025: $17.61 million
Find out what analysts predict for Universal Health Realty Income Trust in the coming months.

Over the last 10 years, Universal Health Realty Income Trust's total revenue changed from $63.95 million in 2015 to $99.19 million in 2025, a change of 55.1%.

Universal Health Realty Income Trust's total liabilities were at $412.52 million at the end of 2025, a 2.8% increase from 2024, and a 56.6% increase since 2015.

In the past 10 years, Universal Health Realty Income Trust's cash and equivalents has ranged from $3.39 million in 2017 to $22.50 million in 2021, and is currently $6.69 million as of their latest financial filing in 2025.

Over the last 10 years, Universal Health Realty Income Trust's book value per share changed from 14.64 in 2015 to 10.98 in 2025, a change of -25.0%.


Related Companies

Financial statements for NYSE:UHT last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel